Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Changes in Stockholders' Deficit

v3.20.1
Condensed Consolidated Statement of Changes in Stockholders' Deficit - USD ($)
Common Stock [Member]
Additional Paid-In-Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2018 $ 670 $ 58,407,257 $ (61,943,318) $ (3,535,391)
Balance, shares at Dec. 31, 2018 669,967      
Common stock grants to independent directors $ 2 87,498 87,500
Common stock grants to independent directors, shares 2,303      
Common stock grants to service providers 6,375 6,375
Common stock grants to service providers, shares 187      
Stock based compensation - options 86,500 86,500
Restricted stock issuances $ 2 44,998 45,000
Restricted stock issuances, shares 1,501      
Extinguishment of derivative liability upon repayment of convertible note      
Net loss (1,135,420) (1,135,420)
Balance at Mar. 31, 2019 $ 674 58,632,628 (63,078,738) (4,445,436)
Balance, shares at Mar. 31, 2019 673,958      
Balance at Dec. 31, 2019 $ 688 59,836,818 (67,036,355) (7,198,849)
Balance, shares at Dec. 31, 2019 687,564      
Common stock grants to independent directors $ 3 18,747 18,750
Common stock grants to independent directors, shares 3,125      
Stock based compensation - options 84,063 84,063
Warrants granted to independent directors 75,000 75,000
Common stock grant to convertible note holders $ 71 434,641 434,712
Common stock grant to convertible note holders, shares 71,409      
Issuance of warrants attached to a convertible note 2,777 2,777
Beneficial conversion feature issued on convertible notes 141,391 141,391
Revaluation of notes payable discounts due to modification of conversion price (214,498) (214,498)
Extinguishment of derivative liability upon repayment of convertible note 78,200 78,200
Net loss (1,002,868) (1,002,868)
Balance at Mar. 31, 2020 $ 762 $ 60,457,139 $ (68,039,223) $ (7,581,322)
Balance, shares at Mar. 31, 2020 762,098